다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Protagonist Therapeutics Inc (PTGX)
Protagonist Therapeutics Inc (PTGX) 뉴스

PTGX

Protagonist Therapeutics (PTGX)

Protagonist Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PTGX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/08	05:51	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/05/08	05:29	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/04/16	22:00	GlobeNewswire Inc.	Turnstone Biologics Appoints William Waddill to its Board of Directors	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	10:27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/02	06:32	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/03/01	07:48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/29	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/28	06:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/14	21:47	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/14	21:15	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/02/01	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/19	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/19	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/16	22:01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/12	10:00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/10	07:25	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/08	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2024/01/05	10:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/12/19	06:15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/11/03	06:07	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/11/03	05:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc
2023/10/31	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PTGX	Protagonist Therapeutics Inc

검색 관련기사 보기:NASDAQ:PTGX

1 2 3 4 5 6 7 8 9 10 다음 >>

China Health Management (PK)

Daiwa Asset Management

Bounce Token [OLD]

Lunr Token (BSC)

Intesa Sanpaolo

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관